Magnetocardiography in the Accurate Identification of Myocardial Infarction

Summary

Magnetocardiography (MCG) is a promising noninvasive and accurate method for detecting myocardial infarction. Although progress has been made in this area, there is a lack of studies using up-to-date examination instruments for the calibration of MCG analysis. This is a prospective single-center study aiming to build accurate analytical models of MCG to detect myocardial infarction. Myocardial infarction are diagnosed by electrocardiogram, biomarkers (high-sensitivity cardiac troponin, etc), or non-invasive imaging (cardiac magnetic resonance or single-photon-emission tomography). Myocardial infarction is also quantified by cardiac magnetic resonance or single-photon-emission tomography. Healthy volunteers and chest pain patients who will receive electrocardiogram, biomarkers (high-sensitivity cardiac troponin, etc), or non-invasive imaging (cardiac magnetic resonance or single-photon-emission tomography) examination will be enrolled in this study.

Conditions

• Chest Pain
• Acute Coronary Syndrome
• Myocardial Infarction

Interventions

DEVICE

Magnetometer

inspection equipment for magnetocardiography

Sponsors & Collaborators

• Chongqing Emergency Medical Center

  collaborator OTHER

• Weifang People's Hospital

  collaborator OTHER

• Linyi People's Hospital

  collaborator OTHER

• Weihai Central Hospital

  collaborator OTHER

• Jining First People's Hospital

  collaborator OTHER

• The First Affiliated Hospital with Nanjing Medical University

  collaborator OTHER

• Second Affiliated Hospital, School of Medicine, Zhejiang University

  collaborator OTHER

• First Affiliated Hospital Xi'an Jiaotong University

  collaborator OTHER

• Guangdong Provincial Hospital of Traditional Chinese Medicine

  collaborator OTHER

• Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

  collaborator OTHER

• Qianfoshan Hospital

  collaborator OTHER

• Heze Municipal Hospital

  collaborator OTHER

• First People's Hospital of Hangzhou

  collaborator OTHER

• Qilu Hospital of Shandong University

  lead OTHER

Principal Investigators

• Yuguo Chen, Dr · Qilu Hospital of Shandong University

Eligibility

Min Age

18 Years

Max Age

79 Years

Sex

ALL

Healthy Volunteers

Yes

Timeline & Regulatory

Start

2023-06-01

Primary Completion

2025-10-31

Completion

2026-12-01

Countries

• China

Study Locations